Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Joel P. Wedd"'
Autor:
Nima Kokabi, Bill S. Majdalany, Bernard Cheng, Alexander Villalobos, Joseph F. Magliocca, M. Cristescu, Minzhi Xing, William Wagstaff, Marty T. Sellers, Linzi Arndt, Joel P. Wedd, Zachary L. Bercu, Anand D. Shah, R. Ermentrout
Publikováno v:
CardioVascular and Interventional Radiology. 44:401-413
To evaluate the efficacy and safety of Y90 radiation segmentectomy (RS) vs. percutaneous microwave ablation (MWA) in patients with solitary HCC ≤ 4 cm. From 2014 to 2017, 68 consecutive treatment naive patients were included (34 per treatment arm).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::721cb4d59b437a53a90e7821955c6bee
https://doi.org/10.1007/s00270-020-02712-1
https://doi.org/10.1007/s00270-020-02712-1
Publikováno v:
Applied Radiology. :10-15
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3064c0924df1370c4ea25876fa012707
https://doi.org/10.37549/ar2665
https://doi.org/10.37549/ar2665
Autor:
Mindie H. Nguyen, Michael K. Turgeon, Juliet Emamaullee, Federico Aucejo, Joseph F. Magliocca, Joel P. Wedd, Dimitrios Moris, Alejandro Chavarriaga, Cyrus A. Feizpour, Mohamed Akoad, Mary Ann Simpson, Ahyoung Kim, Chelsey P. Wongjirad, Reena Salgia, Chandrashekhar A. Kubal, Swaytha Ganesh, Jayme E. Locke, Vijay Subramanian, Marwan M. Kazimi, Benjamin V. Tran, William C. Chapman, Debra L. Sudan, Carlos O. Esquivel, Maia Anderson, Robert M. Cannon, David P. Foley, Matthew P. Anderson, Amika Moro, Ali J. Olyaei, Kiran Dhanireddy, Steven C. Kim, Christopher J. Sonnenday, Majella Doyle, Vatche G. Agopian, Shimul A. Shah, Susan L. Orloff, Shishir K. Maithel, Marwan Abdouljoud, Parsia A. Vagefi, Andrew M. Cameron, Abhinav Humar, Aaron M. Delman
Publikováno v:
Ann Surg
OBJECTIVE: To investigate the optimal timing of direct acting antiviral (DAA) administration in patients with hepatitis C-associated hepatocellular carcinoma (HCC) undergoing liver transplantation (LT). SUMMARY OF BACKGROUND DATA: In patients with he
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05339ce70f3d6d1825db381c7a8a72b1
https://doi.org/10.1097/sla.0000000000005070
https://doi.org/10.1097/sla.0000000000005070
Publikováno v:
Experimental and Clinical Transplantation. 18:741-743
Generalized lymphadenopathy after organ transplant is a concerning finding, often indicating the devel-opment of lymphoma. We describe a 52-year-old liver transplant recipient who had clinical symptoms and imaging concerning for posttransplant lympho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4be5ddadb95bc067ef25d2ca9bf22125
https://doi.org/10.6002/ect.2017.0063
https://doi.org/10.6002/ect.2017.0063
Autor:
Andrew B. Adams, Alexandra G. Lopez-Aguiar, Christina Wu, Rachel M. Lee, Grace Duininck, J.Y. Lin, Joel P. Wedd, Maria C. Russell, Lesley Miller, Sean R. Dariushnia, Shishir K. Maithel, Olatunji B. Alese
Publikováno v:
Journal of Surgical Oncology. 120:1365-1370
BACKGROUND Hepatitis C (HCV) is the primary etiology of hepatocellular carcinoma (HCC) in the US multidisciplinary disease management teams (DMT) that optimize oncologic care. The impact of DMT for HCC in safety-net hospitals is unknown. METHODS Pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8241ac687a6354017c969f5b14360e94
https://doi.org/10.1002/jso.25738
https://doi.org/10.1002/jso.25738
Autor:
Christina Wu, Olatunji B. Alese, Joel P. Wedd, Mehmet Akce, Renjian Jiang, Bassel F. El-Rayes, Katerina Mary Zakka, Marty T. Sellers, Walid L. Shaib, Madhusmita Behera
Publikováno v:
Journal of Hepatocellular Carcinoma. 6:119-129
Background HCC variants are rare primary hepatic tumors. The aim of this study is to compare clinical characteristics and outcomes of HCC variants with pure HCC. Methods Patients diagnosed between 2004 and 2013 with ICD-O-3 8180/3 and 8170/3-8175/3 w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::584071ed0c61e74d255a7e63c5ad6b46
https://doi.org/10.2147/jhc.s215235
https://doi.org/10.2147/jhc.s215235
Autor:
Kavitha Nair, Joel P. Wedd
Publikováno v:
Current Hepatology Reports. 18:9-19
Decompensated cirrhosis and liver failure result in high mortality risk. Identifying the severity of illness and risk of poor outcomes is important for improved clinical decision making. This review serves to examine the currently in practice and dev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a97b97f5999674385fba4f1817ee5ec3
https://doi.org/10.1007/s11901-019-00445-5
https://doi.org/10.1007/s11901-019-00445-5
Autor:
Christina Wu, Dylan J. Martini, Walid L. Shaib, Mehmet Akce, Olatunji B. Alese, Yuan Liu, Joel P. Wedd, Mehmet Asim Bilen, Katerina Mary Zakka, Bassel F. El-Rayes, Amber Draper, Marty T. Sellers
Publikováno v:
American journal of clinical oncology. 44(2)
BACKGROUND Sarcopenia and inflammation are independently associated with worse survival in cancer patients. This study aims to determine the impact of sarcopenia, body mass index (BMI), and inflammatory biomarkers on survival in advanced hepatocellul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4bdda55d8a07f8227de22650fc82ef60
https://pubmed.ncbi.nlm.nih.gov/33350681
https://pubmed.ncbi.nlm.nih.gov/33350681
Autor:
Rachel E. Patzer, Joel P. Wedd, Katherine Ross-Driscoll, Raymond J. Lynch, Laura C. Plantinga, Michael R. Kramer
Publikováno v:
Liver Transpl
Little is known about the role that transplant centers may play in perpetuating racial disparities after liver transplantation, which are unexplained by patient-level factors. We examined variation in between-center and within-center disparities amon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b82a825205378dac8c45250a3e27f4a4
https://pubmed.ncbi.nlm.nih.gov/33037711
https://pubmed.ncbi.nlm.nih.gov/33037711
Autor:
Joel P. Wedd, Thuy-Van P Hang
Publikováno v:
Chinese clinical oncology. 10(1)
Hepatocellular carcinoma (HCC) is the fourth most common cause of cancer related mortality worldwide, with the most common underlying etiologies being chronic hepatitis B and hepatitis C infections. Treatment of these viral hepatidities in the settin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::743d663448d6bed64d86296d822db683
https://pubmed.ncbi.nlm.nih.gov/32527114
https://pubmed.ncbi.nlm.nih.gov/32527114